(Q48392359)

11 February 2018

title

Propranolol in the Treatment of Hypertension (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

11 November 2023

main subject

arterial hypertension

0 references

author name string

O. B. Holland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1256484

11 November 2023

N. M. Kaplan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1256484

11 November 2023

language of work or name

English

0 references

publication date

1 April 1976

1 reference

11 February 2018

22 April 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1256484

full work available at URL

11 November 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197604222941706

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The New England Journal of Medicine

11 November 2023

published in

1 reference

11 February 2018

volume

294

1 reference

11 February 2018

issue

17

1 reference

11 February 2018

page(s)

930-936

1 reference

11 February 2018

Propranolol in hypertension: a study of long-term therapy, 1964-1970

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

11 November 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

11 November 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

11 November 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Essential hypertension: renin and aldosterone, heart attack and stroke.

11 November 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Clinical pharmacology of propranolol

11 November 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

11 November 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol given twice daily in hypertension

11 November 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Pharmacodynamics of Propranolol in Renal Failure

11 November 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Letter: Beta-blockade in the presence of renal disease and hypertension.

11 November 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow

11 November 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man

11 November 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease

11 November 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

11 November 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The paradox of beta-adrenergic blockade in hypertension

11 November 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effects of Chronic Beta-Adrenergic Blockade on Systemic and Renal Haemodynamic Responses to Hyperosmotic Saline in Hypertensive Patients

11 November 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Plasma volume changes with long-term beta-adrenergic blockade

11 November 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Plasma Volume and Extracellular Fluid Volume during Long-Term Treatment with Propranolol in Essential Hypertension

11 November 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Treatment of Hypertension with Propranolol

11 November 2023

20

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Central cardiovascular effects of intracerebroventricular propranolol.

11 November 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Central Hypotensive Activity of dl- and d-Propranolol

11 November 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

British Journal of Pharmacology

11 November 2023

24

48

343

Dollery

1973

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Adrenergic receptor mediation of renin secretion.

11 November 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

11 November 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

11 November 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Plasma renin and blood pressure during treatment with methyldopa

11 November 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

11 November 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat

11 November 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Studies of the absorption and removal of propranolol in hypertensive patients during therapy

11 November 2023

34

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of propranolol in mild hypertension

11 November 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Hypotensive action of propranolol

11 November 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Ineffectiveness of propranolol in hypertensive Jamaicans

11 November 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of propranolol on elevated arterial blood pressure

11 November 2023

39

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

11 November 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

11 November 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension

11 November 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension

11 November 2023

46

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension

11 November 2023

47

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of practolol on blood pressure and renin release in man

11 November 2023

48

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

11 November 2023

49

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

A comparison of beta adrenergic blocking drugs in the treatment of hypertension

11 November 2023

50

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Beta-blockers and plasma renin activity in hypertension.

11 November 2023

52

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Clinical science and molecular medicine

11 November 2023

53

45

287

Johnston

1973

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The New England Journal of Medicine

11 November 2023

54

290

284

Amery

1974

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The New England Journal of Medicine

11 November 2023

55

290

1026

Aberg

1974

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol in hypertension. Report on 158 patients treated up to one year

11 November 2023

56

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol and polythiazide in treatment of hypertension

11 November 2023

58

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

11 November 2023

59

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol in hypertension

11 November 2023

60

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

11 November 2023

61

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Observations on angina pectoris during drug treatment of hypertension

11 November 2023

62

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Antagonism of Guanethidine by Chlorpromazine

11 November 2023

63

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Cardiac complications during treatment with imipramin (Tofranil)

11 November 2023

64

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

The long-term treatment of hypertension with thiazide diuretics

11 November 2023

65

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies

11 November 2023

66

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Cardioadrenergic factor in essential hypertension

11 November 2023

68

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Consecutive haemodynamic patterns in essential hypertension

11 November 2023

69

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol therapy in essential hypertension

11 November 2023

70

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Hypoglycaemia precipitated by propranolol

11 November 2023

71

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol-induced hypoglycaemia and myocardial infarction

11 November 2023

72

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol-induced Insulin Release in Isolated Rat Islets of Langerhans

11 November 2023

73

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Role of adrenergic receptors in glucose-induced insulin secretion in man

11 November 2023

74

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy.

11 November 2023

75

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma

11 November 2023

76

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Hypertensive response to propranolol in a patient treated with methyldopa-a proposed mechanism

11 November 2023

77

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Propranolol and the hyperactive carotid sinus reflex syndrome

11 November 2023

78

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension

11 November 2023

79

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and Hypertension

11 November 2023

80

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

11 November 2023

82

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate

11 November 2023

83

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.

11 November 2023

84

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

11 November 2023

86

1 reference

https://api.crossref.org/works/10.1056/NEJM197604222941706

11 November 2023

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018